Shortage of drug used to treat Black Fungus will be resolved soon, assures Mansukh Mandaviya ANI | Updated: May 20, 2021 21:19 IST
New Delhi [India], May 20 (ANI): Minister of State for Chemicals and Fertilisers Mansukh Mandaviya on Thursday announced that shortage of Amphotericin-B, the drug used for the treatment of Mucormycosis, coomonly known as Black Fungus, a post-COVID complication, shall be resolved soon.
The Minister informed that within three days, five more Pharma companies have received New Drug Approval for producing it in India, in addition to the existing six pharma companies.
The existing pharma companies have already started ramping up the production of the drug, he added.
Will Fix Shortage, 5 More Firms To Make Anti-Black Fungus Drug: Centre Coronavirus: Black Fungus (Mucormycosis) curing drug Amphotericin B s shortage will be resolved soon, Union Minister Mansukh Mandaviya tweeted
Updated: May 20, 2021 7:52 pm IST
Coronavirus: Black Fungus or Mucormycosis infection in COVID-19 patients have been reported
New Delhi:
Five more companies in India have been allowed to make drugs to treat Black Fungus or Mucormycosis, the government said today. Any shortage of medicines to treat the opportunistic fungal infection that s affecting some COVID-19 patients in several states will be resolved soon, Union Minister of State for Chemicals and Fertilisers Mansukh Mandaviya tweeted today.
I was unaware of govt efforts : Nitin Gadkari after suggestion to let more firms make Covid vaccines
Gadkari said he was unaware that the Centre had alreay started these efforts before he had given a suggestion yesterday. This is what Dr Manmohan Singh had suggested on April 18th. But is his Boss listening, asks Congress Jairam Ramesh
BusinessToday.In | May 19, 2021 | Updated 15:10 IST
Union minister Nitin Gadkari
After Union minister Nitin Gadkari sparked a controversy over the huge demand for vaccines against production in the country, he clarified today saying he was unaware of the fact that the Centre is already facilitating vaccine manufacturing by 12 different plants or companies.
No gap between demand, supply of Remdesivir in India, says Mansukh Mandaviya ANI | Updated: May 19, 2021 14:39 IST
By Amit Kumar
New Delhi [India], May 19 (ANI): There is no gap between demand and supply of Remdesivir, said Union Minister of State for Chemicals and Fertilisers Mansukh Mandaviya on Wednesday, adding that the production of Remdesivir has been ramped up to produce 3.25 lakh vials daily. There is currently no gap between demand and supply of Remdesivir injection. The country is producing 3.25 lakh of vials daily to meet the requirements, Mandaviya said.
As the nation battles the second wave of the pandemic, the demand for Remdesivir surged resulting in a shortage of the drug used in the treatment of COVID-19 patients.
Last Updated:
Congress Hails Nitin Gadkari s Vaccine Shortage Admission: one BJP Minister Waking Up
Congress spokesperson Jaiveer Shergill claimed that the BJP-led central govt was providing the people of India with fake toolkits in place of COVID vaccines
PTI / ANI image composite
Congress spokesperson Jaiveer Shergill claimed that the BJP-led central government was providing the people of India with fake toolkits in place of COVID-19 vaccines as the country battled the second wave of the pandemic. The Congress leader s remarks come after Union Minister Nitin Gadkari on Wednesday opined that demand for COVID vaccines exceeding supply could lead to a problem for India. Reacting to Gadkari s statement, Congress Jaiveer Shergill said that he felt good to know that a BJP minister had woken up to reality and asked how many more people had to die for the system to arouse itself. It is pertinent to point out that Union Minister Gadkari had later on clarified that he w